Works matching IS 2076393X AND DT 2025 AND VI 13 AND IP 1
Results: 96
Impact of HPV Catch-Up Vaccination on High-Grade Cervical Lesions (CIN2+) Among Women Aged 26–30 in Northern Norway.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 96, doi. 10.3390/vaccines13010096
- By:
- Publication type:
- Article
Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A Viruses.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 95, doi. 10.3390/vaccines13010095
- By:
- Publication type:
- Article
Enhancing DNA Vaccine Delivery Through Stearyl-Modified Cell-Penetrating Peptides: Improved Antigen Expression and Immune Response In Vitro and In Vivo.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 94, doi. 10.3390/vaccines13010094
- By:
- Publication type:
- Article
Robust and Long-Lasting Immunity and Protection in Mice Induced by Lipopolyplex-Delivered mRNA Vaccines Expressing the Prefusion Protein of Respiratory Syncytial Virus.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 93, doi. 10.3390/vaccines13010093
- By:
- Publication type:
- Article
Advancing the Fight Against Cervical Cancer: The Promise of Therapeutic HPV Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 92, doi. 10.3390/vaccines13010092
- By:
- Publication type:
- Article
A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 91, doi. 10.3390/vaccines13010091
- By:
- Publication type:
- Article
Antibody Responses to mRNA COVID-19 Vaccine Among Healthcare Workers in Outpatient Clinics in Japan.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 90, doi. 10.3390/vaccines13010090
- By:
- Publication type:
- Article
Protective Efficacy of Decreasing Antigen Doses of a Chlamydia abortus Subcellular Vaccine Against Ovine Enzootic Abortion in a Pregnant Sheep Challenge Model.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 89, doi. 10.3390/vaccines13010089
- By:
- Publication type:
- Article
Negative Association of Gulf War Illness Symptomatology with Predicted Binding Affinity of Anthrax Vaccine Antigen to Human Leukocyte (HLA) Class II Molecules.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 88, doi. 10.3390/vaccines13010088
- By:
- Publication type:
- Article
NIAID Workshop Report: Systematic Approaches for ESKAPE Bacteria Antigen Discovery.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 87, doi. 10.3390/vaccines13010087
- By:
- Publication type:
- Article
The Long-Term Immunity of a Microneedle Array Patch of a SARS-CoV-2 S1 Protein Subunit Vaccine Irradiated by Gamma Rays in Mice.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 86, doi. 10.3390/vaccines13010086
- By:
- Publication type:
- Article
Safety, Immunogenicity, and Efficacy of Cytomegalovirus Vaccines: A Systematic Review of Randomized Controlled Trials.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 85, doi. 10.3390/vaccines13010085
- By:
- Publication type:
- Article
Immunogenicity of HIV-1 Env mRNA and Env-Gag VLP mRNA Vaccines in Mice.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 84, doi. 10.3390/vaccines13010084
- By:
- Publication type:
- Article
Provider Preference, Logistical Challenges, or Vaccine Hesitancy? Analyzing Parental Decision-Making in School Vaccination Programs: A Qualitative Study in Sydney, Australia.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 83, doi. 10.3390/vaccines13010083
- By:
- Publication type:
- Article
Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in Adults.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 82, doi. 10.3390/vaccines13010082
- By:
- Publication type:
- Article
The Development of a Novel Broad-Spectrum Influenza Polypeptide Vaccine Based on Multi-Epitope Tandem Sequences.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 81, doi. 10.3390/vaccines13010081
- By:
- Publication type:
- Article
Strengthening National Immunization Technical Advisory Groups: Twelve Years of Progress (2012–2023).
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 80, doi. 10.3390/vaccines13010080
- By:
- Publication type:
- Article
Inactivation of Zika Virus with Hydroxypropyl-Beta-Cyclodextrin.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 79, doi. 10.3390/vaccines13010079
- By:
- Publication type:
- Article
Elegant and Innovative Recoding Strategies for Advancing Vaccine Development.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 78, doi. 10.3390/vaccines13010078
- By:
- Publication type:
- Article
Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 77, doi. 10.3390/vaccines13010077
- By:
- Publication type:
- Article
The Role of Dendritic Cells in Adaptive Immune Response Induced by OVA/PDDA Nanoparticles.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 76, doi. 10.3390/vaccines13010076
- By:
- Publication type:
- Article
Development of RT-PCR Assays for Simple Detection and Identification of Sabin Virus Contaminants in the Novel Oral Poliovirus Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 75, doi. 10.3390/vaccines13010075
- By:
- Publication type:
- Article
Single Dose of Attenuated Vaccinia Viruses Expressing H5 Hemagglutinin Affords Rapid and Long-Term Protection Against Lethal Infection with Highly Pathogenic Avian Influenza A H5N1 Virus in Mice and Monkeys.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 74, doi. 10.3390/vaccines13010074
- By:
- Publication type:
- Article
Strategic and Technical Considerations in Manufacturing Viral Vector Vaccines for the Biomedical Advanced Research and Development Authority Threats.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 73, doi. 10.3390/vaccines13010073
- By:
- Publication type:
- Article
Exploitation of Unconventional CD8 T-Cell Responses Induced by Engineered Cytomegaloviruses for the Development of an HIV-1 Vaccine.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 72, doi. 10.3390/vaccines13010072
- By:
- Publication type:
- Article
Seasonal Influenza Vaccination Uptake Among Australian Healthcare Professionals: An Archetype for Success.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 71, doi. 10.3390/vaccines13010071
- By:
- Publication type:
- Article
T4 Phage Displaying Dual Antigen Clusters Against H3N2 Influenza Virus Infection.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 70, doi. 10.3390/vaccines13010070
- By:
- Publication type:
- Article
Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 69, doi. 10.3390/vaccines13010069
- By:
- Publication type:
- Article
Development and Evaluation of the Immunogenic Potential of an Unmodified Nucleoside mRNA Vaccine for Herpes Zoster.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 68, doi. 10.3390/vaccines13010068
- By:
- Publication type:
- Article
Comparing Antibody Responses to Homologous vs. Heterologous COVID-19 Vaccination: A Cross-Sectional Analysis in an Urban Bangladeshi Population.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 67, doi. 10.3390/vaccines13010067
- By:
- Publication type:
- Article
Pertussis Vaccination for Adults: An Updated Guide for Clinicians.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 60, doi. 10.3390/vaccines13010060
- By:
- Publication type:
- Article
Live Plague Vaccine Development: Past, Present, and Future.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 66, doi. 10.3390/vaccines13010066
- By:
- Publication type:
- Article
Neo-BCV: A Novel Bacterial Liquid Complex Vaccine for Enhancing Dendritic Cell-Mediated Immune Responses Against Lung Cancer.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 64, doi. 10.3390/vaccines13010064
- By:
- Publication type:
- Article
Determinants of Rotavirus Vaccine Acceptance in an Area of Southern Italy with Low Vaccination Coverage: A Case-Control Study by the Health Belief Model Questionnaire.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 63, doi. 10.3390/vaccines13010063
- By:
- Publication type:
- Article
The Role of Partnerships in Supporting COVID-19 Vaccine Uptake Among Migrants: A Qualitative Case Study from Tamil Nadu and Punjab, India.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 62, doi. 10.3390/vaccines13010062
- By:
- Publication type:
- Article
Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 61, doi. 10.3390/vaccines13010061
- By:
- Publication type:
- Article
Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 65, doi. 10.3390/vaccines13010065
- By:
- Publication type:
- Article
Genetically Engineered Bacterial Ghosts as Vaccine Candidates Against Klebsiella pneumoniae Infection.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 59, doi. 10.3390/vaccines13010059
- By:
- Publication type:
- Article
Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in Mice.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 58, doi. 10.3390/vaccines13010058
- By:
- Publication type:
- Article
Surveillance of Adverse Events Following Varicella Vaccine Immunization in Zhejiang Province, China, from 2020 to 2022.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 57, doi. 10.3390/vaccines13010057
- By:
- Publication type:
- Article
Exploring Future Pandemic Preparedness Through the Development of Preventive Vaccine Platforms and the Key Roles of International Organizations in a Global Health Crisis.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 56, doi. 10.3390/vaccines13010056
- By:
- Publication type:
- Article
Barriers and Predictors of Lyme Disease Vaccine Acceptance: A Cross-Sectional Study in Poland.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 55, doi. 10.3390/vaccines13010055
- By:
- Publication type:
- Article
Evaluating Families' Opinions of Routine Influenza Vaccination in Children Under 5 Years of Age in Spain.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 54, doi. 10.3390/vaccines13010054
- By:
- Publication type:
- Article
Evaluating the Efficacy and Safety of Hepatitis E Vaccination in Reproductive-Age Women: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 53, doi. 10.3390/vaccines13010053
- By:
- Publication type:
- Article
An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory Disease.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 52, doi. 10.3390/vaccines13010052
- By:
- Publication type:
- Article
Peptide Antigen Modifications Influence the On-Target and Off-Target Antibody Response for an Influenza Subunit Vaccine.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 51, doi. 10.3390/vaccines13010051
- By:
- Publication type:
- Article
Rotavirus Vaccination Protects Against Diabetes Mellitus Type 1 in Children in Developed Countries: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 50, doi. 10.3390/vaccines13010050
- By:
- Publication type:
- Article
Developing an Effective Therapeutic HPV Vaccine to Eradicate Large Tumors by Genetically Fusing Xcl1 and Incorporating IL-9 as Molecular Adjuvants.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 49, doi. 10.3390/vaccines13010049
- By:
- Publication type:
- Article
Safety, Tolerability, and Immunogenicity of the Invaplex AR-Detox Shigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 48, doi. 10.3390/vaccines13010048
- By:
- Publication type:
- Article
A Spike-Based mRNA Vaccine Encapsulated in Phospholipid 1,2-Dioleoyl-sn-Glycero-3-PhosphoEthanolamine Containing Lipid Nanoparticles Induced Potent B- and T-Cell Responses Associated with Protection Against SARS-CoV-2 Infection and COVID-19-like Symptoms in Hamsters
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 47, doi. 10.3390/vaccines13010047
- By:
- Publication type:
- Article